The Value of Inflammatory Prognostic Index in Older Patients with Hormone Receptor Positive Metastatic Breast Cancer

Simple item page
dc.contributor.authorAtike Pinar Erdogan
dc.contributor.authorFerhat Ekinci
dc.contributor.authorAhmet Ozveren
dc.contributor.authorSenem Yilmaz
dc.contributor.authorMustafa Sahin
dc.contributor.authorBilgin Demir
dc.contributor.authorEsin Oktay
dc.contributor.authorAhmet Dirican
dc.date.accessioned2024-07-24T09:11:38Z
dc.date.available2024-07-24T09:11:38Z
dc.date.issued2021
dc.description.abstractObjectives: To search the prognostic value of an inflammation based prognostic score in older patients with hormone positive, Her2 negative metastatic breast cancer. Methods: A retrospective study of 82 female patients aged 65 years and older with hormon receptor positive, Her-2 negative metastatic breast cancer diagnosed between 2011 and 2018 was conducted with collection of clinical and laboratory data. The inflammatory prognostic index (IPI) was calculated as C-reactive protein × NLR (neutrophil/ lym- phocyte ratio)/serum albumin. Survival estimates were calculated with Kaplan-Meier method. Results: The optimal cut-off points of IPI for the stratification of OS was found to be 0,75. Based on this cutoff value, patients were categorized as IPI-high and IPI-low group. High IPI was significantly associated with advanced stage at diagnosis. (p=0.03) The mean OS was 64 months in the IPI-high group and 66.9 months in the IPI-low group. (p=0,813) In patients receiving hormonotherapy in first line treatment PFS was 34.6 months in the IPI-low group and 14.5 months in the IPI high group, and a statistically significant difference was found compared to patients who received chemo- therapy in the first line. (p=0,042). Conclusion: Measurement of systemic inflammatory response in older adults with metastatic breast cancer is reliable, available, and can be clinically incorporated into current geriatric oncology algorithms
dc.identifier.DOI-ID10.14744/ejmi.2021.09037
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/23859
dc.language.isoeng
dc.titleThe Value of Inflammatory Prognostic Index in Older Patients with Hormone Receptor Positive Metastatic Breast Cancer
dc.typeAraştırma Makalesi

Files

Collections

TR-Dizin Koleksiyonu